Table 3.
Clinical characteristics of the replication cohort
| PH (%) |
|||||
|---|---|---|---|---|---|
| Total (n = 580) | Absence (n = 510) | Presence (n = 70) | P | OR (95% CI) | |
| Sex, male (%) | 287 (49.5) | 256 (50.2) | 31 (44.3) | 0.35 | 0.79 (0.48–1.30) |
| CE (%) | 286 (49.8) | 239 (47.3) | 47 (68.1) | 0.001* | 2.38 (1.39–4.06) |
| Age, years (IQR) | 71 (60–78) | 70 (59–78) | 74 (68–80) | 0.004* | |
| Diabetes, yes (%) | 42 (12.9) | 35 (12.7) | 7 (13.7) | 0.84 | 1.09 (0.46–2.61) |
| Baseline NIHSS (IQR) | 10 (6–17) | 9 (5–15) | 16 (11–19) | <0.001* | |
For categorical variables, frequencies were described as percentages. For continuous variables, median values and interquartile range (IQR) were calculated. CE = cardioembolism aetiology by trial of Org 1072 in Acute Stroke Treatment classification; PH = parenchymal haematoma.
*P-value < 0.05.